Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
OCULAR THERAPEUTIX, INC | Chief Development Officer | Common Stock | 216K | $1.95M | $9.02 | Oct 2, 2024 | Direct |
OCULAR THERAPEUTIX, INC | Chief Development Officer | Stock Option (Right to Buy) | 200K | Oct 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OCUL | OCULAR THERAPEUTIX, INC | Oct 2, 2024 | 2 | $0 | 4 | Oct 4, 2024 | Chief Development Officer |
OCUL | OCULAR THERAPEUTIX, INC | Oct 2, 2024 | 0 | $0 | 3 | Oct 4, 2024 | Chief Development Officer |